The FDA granted breakthrough therapy designation to TERN-701 for adults with Philadelphia chromosome-positive CML without the ...
MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
MSD (Merck) will acquire Terns Pharmaceuticals for approximately USD 6.7 billion, adding investigational leukemia therapy ...
Stakeholders are reluctant to publicly speculate on how much thresholds should be increased. Credit: Iryna Imago via Shutterstock. · Pharmaceutical Technology · Iryna Imago via Shutterstock. The above ...
MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...
Madhuri Dixit has partnered with MSD India for a nationwide cervical cancer awareness initiative aimed at encouraging women ...
Merck & Co (MSD) has taken the first of two possible plunges in its ongoing collaboration with Evaxion, gaining the rights to a mystery infectious disease vaccine candidate. The US big pharma decided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results